Drawing for LUCANE PHARMA

USPTO serial 79115136

LUCANE PHARMA

Reviewed by CopyMark Law Group

Reg. 4352108Status 404
Filing date
Status date
Registration date
Jun 18, 2013
Examiner
MEIER, SHARON A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LUCANE PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Caroline L. Stevens

Caroline L. Stevens Leydig, Voit & Mayer, Ltd.Two Prudential Plaza, Suite 4900Chicago, IL 60601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified, and injury and poisoningSECTION 71 - CANCELLED—
042Pharmaceutical research servicesSECTION 71 - CANCELLED—
044Pharmacy advice, namely, pharmaceutical adviceSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 26, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Dec 26, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 12, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 7, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 13, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 13, 2020INPCINVALIDATION PROCESSED—
Sep 24, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 24, 2020C71TCANCELLED SECTION 71—
Jun 18, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 15, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 20, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 20, 2013FIMPFINAL DISPOSITION PROCESSED—
Sep 18, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 18, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 26, 2013GPNXNOTIFICATION PROCESSED BY IB—
Apr 2, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 13, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 13, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 25, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 24, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 31, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 31, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2013ALIEASSIGNED TO LIE—
Jan 22, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2012RFNTREFUSAL PROCESSED BY IB—
Sep 24, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 24, 2012RFRRREFUSAL PROCESSED BY MPU—
Sep 24, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 23, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2012DOCKASSIGNED TO EXAMINER—
Aug 11, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 7, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance